# Effect of SLC01B1 (rs4149956) Polymorphism on the Efficacy and Tolerability of Atorvastatin in Pakistani Population

> **NCT07148037** · — · COMPLETED · sponsor: **Riphah International University** · enrollment: 150 (actual)

## Conditions studied

- Hyperlipidemias

## Interventions

- **GENETIC:** Atorvastatin

## Key facts

- **NCT ID:** NCT07148037
- **Lead sponsor:** Riphah International University
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2024-09-01
- **Primary completion:** 2025-07-31
- **Final completion:** 2025-07-31
- **Target enrollment:** 150 (ACTUAL)
- **Last updated:** 2025-08-29


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07148037

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07148037, "Effect of SLC01B1 (rs4149956) Polymorphism on the Efficacy and Tolerability of Atorvastatin in Pakistani Population". Retrieved via AI Analytics 2026-06-26 from https://api.ai-analytics.org/clinical/NCT07148037. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*